{
    "clinical_study": {
        "@rank": "11412", 
        "arm_group": {
            "arm_group_label": "Dasatinib (100 mg)", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study proposes to evaluate the number of chronic, Grade 1 or 2, non-hematologic Adverse\n      Events (AEs) that reduce in grade or resolve at 3 months after switching therapy from\n      imatinib to dasatinib."
        }, 
        "brief_title": "This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Phase Chronic Myeloid Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid", 
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
                "Leukemia, Myeloid, Chronic-Phase"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with CML-CP patients achieving an optimal response to imatinib treatment\n             with Grade 1 or 2 non-hematologic adverse events persisting for at least 2 months or\n             recurring at least 3 times in the preceding 12 months, despite best supportive care\n\n          -  Men and women with Chronic Myeloid Leukemia- Chronic Phase (CML-CP) Ph+ \u2265 age 18\n\n          -  Daily Eastern Co-Operative Group (ECOG) performance status = 0 - 2\n\n          -  Patient willing and able to give informed consent\n\n          -  Life expectancy > 6 months\n\n          -  Adequate renal function\n\n          -  Adequate hepatic function\n\n        Exclusion Criteria:\n\n          -  Patients who are pregnant or breast feeding\n\n          -  Men whose partner is unwilling to avoid pregnancy.\n\n          -  Previous treatment with any other tyrosine-kinase inhibitor (TKI), except for\n             imatinib\n\n          -  Current grade 3 or 4 imatinib related adverse event\n\n          -  Prior documented T315I mutation\n\n          -  Prior diagnosis of accelerated phase or blast crisis CML\n\n          -  Previous loss of complete hematologic response (CHR) or major cytogenetic response\n             (MCyR) on imatinib\n\n          -  Concurrent medical condition of uncontrolled infection, cardiovascular diseases of\n             cardiac failure, congenital long QT syndrome, ventricular arrhythmias, prolonged QT\n             interval,  second or third degree heart block, uncontrolled angina, myocardial\n             infarction (MI) in the last 6 months, uncontrolled hypertension, pulmonary arterial\n             hypertension, pleural or pericardial effusions, or history of bleeding disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660906", 
            "org_study_id": "CA180-400", 
            "secondary_id": "2011\u2010006180\u201021"
        }, 
        "intervention": {
            "arm_group_label": "Dasatinib (100 mg)", 
            "description": "tablets, oral, 100 mg, Once daily, Up to12 months on study,", 
            "intervention_name": "Dasatinib", 
            "intervention_type": "Drug", 
            "other_name": "Sprycel"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Imatinib", 
                "Dasatinib"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 27, 2014", 
        "link": [
            {
                "description": "BMS Clinical Trial Information", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "BMS clinical trial educational resource", 
                "url": "http://www.bms.com/studyconnect/Pages/home.aspx"
            }, 
            {
                "description": "Investigator Inquiry form", 
                "url": "http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"
            }, 
            {
                "description": "FDA Safety Alerts and Recalls", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "contact": {
                    "last_name": "Ajit Maniam, Site 0002"
                }, 
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Pacific Cancer Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Peter Byeff, Site 0001"
                }, 
                "facility": {
                    "address": {
                        "city": "Southington", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06489"
                    }, 
                    "name": "Cancer Center Of Central Connecticut"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Carole B Miller, Site 0003"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21229"
                    }, 
                    "name": "St. Agnes Healthcare, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "William R. Horvath, Site 0013"
                }, 
                "facility": {
                    "address": {
                        "city": "Sylvania", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43560"
                    }, 
                    "name": "Promedica Hematology & Oncology Assoicates"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jorge E Cortes, Site 0004"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "The University Of Texas Md Anderson Cancer Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0023"
                }, 
                "facility": {
                    "address": {
                        "city": "Creteil Cedex", 
                        "country": "France", 
                        "zip": "94010"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0017"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille CEDEX", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0014"
                }, 
                "facility": {
                    "address": {
                        "city": "Pierre Benite cedex", 
                        "country": "France", 
                        "zip": "69495"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0016"
                }, 
                "facility": {
                    "address": {
                        "city": "Pringy Cedex", 
                        "country": "France", 
                        "zip": "74374"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0015"
                }, 
                "facility": {
                    "address": {
                        "city": "Vandoeuvre les Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0007"
                }, 
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "07747"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0019"
                }, 
                "facility": {
                    "address": {
                        "city": "Koln", 
                        "country": "Germany", 
                        "zip": "50937"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0020"
                }, 
                "facility": {
                    "address": {
                        "city": "Lubeck", 
                        "country": "Germany", 
                        "zip": "23562"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0009"
                }, 
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "zip": "68169"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0008"
                }, 
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "zip": "18055"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0011"
                }, 
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy", 
                        "zip": "95124"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0006"
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50134"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0005"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00144"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0012"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00161"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0010"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0022"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "137-701"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "France", 
                "Germany", 
                "Italy", 
                "Korea, Republic of"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib", 
        "overall_contact": {
            "email": "Clinical.Trials@bms.com", 
            "last_name": "Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:"
        }, 
        "overall_contact_backup": {
            "last_name": "First line of the email MUST contain NCT# and Site #."
        }, 
        "overall_official": {
            "affiliation": "Bristol-Myers Squibb", 
            "last_name": "Bristol-Myers Squibb", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration", 
                "European Union: European Medicines Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Frequency of reduction in grade (Grade 2 to 1) or resolution of imatinib-related chronic Grade 1 or Grade 2 non-hematologic AEs at 3 months after switch to dasatinib", 
            "safety_issue": "Yes", 
            "time_frame": "3 months after switch to dasatinib"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660906"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in patient reported CML symptom severity by Mean change in M.D. Anderson Symptom Inventory- Chronic Myeloid Leukemia (MDASI-CML) score", 
                "safety_issue": "Yes", 
                "time_frame": "3, 6, 12 months"
            }, 
            {
                "measure": "Change in patient reported quality of life measured by EORTC-Quality of Life Questionnaire score", 
                "safety_issue": "No", 
                "time_frame": "6, 12 months"
            }, 
            {
                "measure": "Frequency of dasatinib-related adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 12 months"
            }, 
            {
                "measure": "Proportion of patients with reduction or improvement of at least 1 imatinib-related Grade 1 or Grade 2 chronic AE, without a worsening of any imatinib-related, chronic adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Rate of major molecular response", 
                "safety_issue": "No", 
                "time_frame": "6, 12 months"
            }
        ], 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}